Table 2

Tissue-to-plasma ratios of AZT-MP at 90 min after dosing

	Bone Marrow^2-a	Lymph Nodes^2-b	Spleen^2-b	Thymus^2-b	Brain^2-b	Liver^2-b	Kidneys^2-b	Lung^2-b	Heart^2-b	Muscle^2-b
Control	6.31^2-c	0.490	2.54^2-c	0.451	0.148	1.387^2-c	4.32^2-c	0.813	1.13	0.781
	±2.55	±0.124	±0.907	±0.345	±0.065	±0.107	±0.449	±0.036	±0.231	±0.275

Infected	5.49^2-c	1.16^2-c ^, ^2-d	2.08^2-c	1.11^2-c ^, ^2-d	0.057^2-d	1.074^2-c	2.23^2-c ^, ^2-d	0.892	0.600^2-d	0.478^2-c
	±2.41	±0.314	±0.035	±0.274	±0.019	±0.119	±0.162	±0.048	±0.029	±0.096

Ratios of tissue-to-plasma levels of AZT-MP of control and LP-BM5 MuLV-inoculated animals at 90 min after subcutaneous administration of a 25 mg/kg dose of AZT. Data are mean ±1 SD of four mice.

↵2-a Tissue-to-plasma ratios are presented as dpm/10¹⁰ cells over dpm/ml plasma.
↵2-b Tissue-to-plasma ratios are presented as dpm/g tissue over dpm/ml plasma.
↵2-c Significantly different from the respective tissue-to-plasma ratios of AZT at 90 min after dosing (AZT data are shown in table 1), p < 0.05.
↵2-d Significantly different from the respective values of the control animals, p < 0.05.